Imaging techniques such as X-rays, CT scans, MRI, and PET scans, which help visualize the tumor.
Biopsy, where a small sample of tissue is removed for examination under a microscope to determine if cancer cells are present.
Blood tests for tumor markers, which are substances produced by cancer cells that can be detected in the blood.
Endoscopy, a procedure where a flexible tube with a camera is inserted into the body to look at internal organs directly.
Genetic testing to identify mutations in genes that may indicate a predisposition to certain cancers.
Monitor the
size and location of the tumor during treatment to assess its response to therapy.
Guide surgical procedures by providing real-time images to ensure precise removal of cancerous tissues while sparing healthy tissues.
Plan and deliver
radiation therapy by mapping out the exact location of the tumor to maximize the dose to cancer cells while minimizing exposure to surrounding healthy tissues.
Polymerase Chain Reaction (PCR), which amplifies DNA sequences to detect genetic mutations associated with cancer.
Next-Generation Sequencing (NGS), which allows for comprehensive analysis of multiple genes or entire genomes to identify genetic alterations in cancer cells.
Microarray analysis, which examines the expression levels of thousands of genes simultaneously to identify patterns associated with different types of cancer.
CRISPR-Cas9 gene editing, which enables precise modification of genes to study their function in cancer development and identify potential therapeutic targets.
Identifying specific
molecular targets that are crucial for the growth and survival of cancer cells.
Developing drugs or biological agents, such as monoclonal antibodies, that specifically interact with these targets to inhibit their function.
Conducting
preclinical studies to assess the efficacy and safety of these agents in cell cultures and animal models.
Performing
clinical trials to evaluate the effectiveness and safety of the new therapies in humans, starting with small groups of patients and gradually expanding to larger populations.
Enhancing the ability of the immune system to recognize and attack cancer cells by using
checkpoint inhibitors that block proteins inhibiting immune responses.
Employing
CAR-T cell therapy, where a patient's own T cells are genetically modified to target and kill cancer cells.
Using
cancer vaccines to stimulate the immune system to recognize and destroy cancer cells.
Combining immunotherapy with other treatments, such as chemotherapy and radiation, to improve overall treatment outcomes.
Analyzing the genetic, molecular, and cellular profiles of a patient's tumor to identify specific
biomarkers and genetic mutations.
Developing personalized treatment plans based on these profiles, including the use of targeted therapies and immunotherapies.
Monitoring treatment response and adjusting the therapy as needed to optimize outcomes.
Reducing the likelihood of adverse effects by selecting treatments that are more likely to be effective based on the patient's unique tumor characteristics.